DNM2 and amyotrophic lateral sclerosis: The cytoskeletal protein NfL and its phosphorylated form, pNfH, are increasingly recognized as the most promising diagnostic biomarkers for ALS [110,119,120], which are correlated to rapid progression and a worse prognosis of the disease [121,122].